Skip To Main Content
Jaimin Shah on Muck Rack

Jaimin Shah

Ahmedabad
As seen in: Nature, Wiley Online Library, MDPI, Royal Society of Chemistry, YourStory, Databricks, Mondaq, The Cureus Journal of Medical Science, Reproductive BioMedicine Online, Bond Vigilantes
born to play wid algorithms...nd addicted to programming....

Get in touch with Jaimin

Contact Jaimin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jaimin Shah’s Biography

Read Full Bio →

i'm jaimin shah..student of computer engineering...blogger,thinker,engineer and founder of http://javagtu.blogspot.in,and lv to know new thinks from the world...and i jst lv the web...

Jaimin Shah’s Journalist Portfolio

Java examples

Java examples

jaimin shah Hey all... i'm jaimin shah..student of computer engineering...blogger,thinker, engineer and found…

View article →

Articles

Expanding the Motor Band Sign in Motor Neuron Disease Using 7T MRI: Visualization of Cortical Layer‐Dependent Iron Deposition in the Primary Motor Cortex

|
By Jaimin Shah, Björn Oskarsson, Xiangzhi Zhou
| Wiley Online Library Verified
Disclosure The authors have nothing to report. Conflicts of Interest Erik Middlebrooks, M.D., has served as a speaker for Siemens Healthineers AG. The remaining authors have no conflicts of interest to disclose. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
Open in Who Shared Issue with article?

Liposomal Oncolytic Adenovirus Enables Efficient CAR-Independent Transduction of Tumors and Enhances NK Cell-Mediated Abscopal Responses

|
By Tao Dong, Jaimin Shah, Abraham T. Phung, Sarah Blair
| dx.doi.org
Open in Who Shared Issue with article?

Liposomal oncolytic adenovirus as a neoadjuvant therapy for triple-negative breast cancer - Scientific Reports

|
By Jaimin Shah, Tao Dong, Abraham T. Phung, Omonigho Aisagbonhi
| Nature Verified
Abstract Breast cancer remains one of the leading causes of cancer-related death, with triple-negative breast cancer (TNBC) accounting for 15–20% of cases. TNBC, characterized by the absence of ER, PR, and HER2 protein, is an aggressive form of breast cancer that is unresponsive to hormonal therapies and HER2-targeted treatments, with fewer treatment options and poorer prognosis.
Open in Who Shared Issue with article?
See all 21 articles